National Mantle Cell Lymphoma Trial - Phase II Randomized Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2015
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Fludarabine
- Indications Mantle-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 20 Dec 2012 Additional lead trial centre identified as reported by United Kingdom Clinical Research Network.
- 05 Nov 2009 Additional lead trial centre, trial locations identified as reported by United Kingdom Clinical Research Network record.
- 05 Nov 2009 New source identified and integrated (United Kingdom Clinical Research Network).